PATHELEN^® Hybrid Vet is a wound powder which contains both hydrophilic and hydrophobic silicas in a highly porous structure. Through capillary action, these silicas
act to irreversibly adsorb wound exudative material (including bacterial toxins) to the upper surface of the layers of the powder from where it effectively evaporates.

PATHELEN^® Hybrid Vet thus “de-toxifies” and cleans the wound.

PATHELEN^® Hybrid Vet is not antibacterial but withdraws water from a bacterial biofilm, disrupting its structure and allowing the host’s immune system to gain entry and destroy the microorganisms present.

Due to its mode of action, PATHELEN^® Hybrid Vet is able to treat a WIDE range of acute and chronic wounds.

Infected wounds*
Exuding Wounds
Wounds with resistant nuclei
Traumatic wounds
Any open wounds with a biofilm

PATHELEN^® Hybrid Vet works most efficiently when a biofilm is present on the wound. It should not be used if there are obvious signs of infection i.e., erythema, swelling, warmth, beyond the wound.

 
^{*Based on independent case study (Italy 2020)}

By disrupting the wound’s biofilm, it allows entry of the animal's body’s own immune cells, which destroy microorganisms within the biofilm, promoting the natural healing process and reducing the need for antibiotics.

PATHELEN^® Hybrid Vet is an effective and powerful replacement for all other currently available antimicrobial wound treatment devices.

Clinical practice shows that the current, individual use of other antimicrobial agents in the treatment of purulo-inflammatory diseases and purulent wounds, does not always lead to the desired result. Additionally, misuse of antibiotics has contributed to the emergence of resistant (hospital) strains of pathogenic microorganisms, including methicillin-resistant Staphylococcus aureus (MRSA), and become a serious challenge for modern medicine.

PATHELEN^® Hybrid can solve this problem, utilising new compositions based on highly dispersed silicas and which have enhanced absorptive, anti-inflammatory and wound-healing abilities for the treatment of a wide range of diseases caused by pathogenic microorganisms, in particular, purulent wounds. The intensity of the regeneration process and healing of infected ulcers and wounds depends largely on the speed with which they are cleared of pus and necrotic tissues. Applique sorption, a method of wound healing in which an absorbent in powder form is applied to the wound as a dressing, greatly accelerates this process. This absorption detoxification restores the integrity of the skin and mucous membranes by the removal of microbial cells, bacterial toxins and toxic metabolites of wound fluid and wound cavities in direct contact with the surface of PATHELEN^®.

Another important therapeutic factor in the first phase of wound healing is dehydration, i.e. absorption of fluid from the wound cavity and perifocal tissues. Hydrophilic highly dispersed silica (HDS) can be used in the first phase of wound healing. Its detoxifying action is due to the absorption of pathogenic protein substances (up to 800 mg/g), including microbial enzymes, exo-and endotoxins (Lipopolysaccharides) and micro-organisms.

Medical Device Class I - EMA European Medicine Agency (CE) Swissmedic registered under CH-201805-0002

U.S. FDA Regulation Number 3017399130
Nigerian NAFDAC 03-6974
Ghana FDA FDA/D.19-3044